Literature DB >> 23257228

Linezolid for multidrug-resistant tuberculosis.

Helen Cox, Nathan Ford, Jennifer Hughes, Eric Goemaere.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23257228     DOI： 10.1016/S1473-3099(12)70299-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  Treatment Outcomes Among Pediatric Patients With Highly Drug-Resistant Tuberculosis: The Role of New and Repurposed Second-Line Tuberculosis Drugs.

Authors:  Tea Madzgharashvili; Argita D Salindri; Matthew J Magee; Nestani Tukvadze; Zaza Avaliani; Henry M Blumberg; Russell R Kempker; Nino Lomtadze
Journal:  J Pediatric Infect Dis Soc       Date:  2021-04-30       Impact factor: 3.164

2.  Linezolid for drug-resistant pulmonary tuberculosis.

Authors:  Bhagteshwar Singh; Derek Cocker; Hannah Ryan; Derek J Sloan
Journal:  Cochrane Database Syst Rev       Date:  2019-03-20

3.  Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.

Authors:  Anthony J Garcia-Prats; H Simon Schaaf; Heather R Draper; Maria Garcia-Cremades; Jana Winckler; Lubbe Wiesner; Anneke C Hesseling; Rada M Savic
Journal:  PLoS Med       Date:  2019-04-30       Impact factor: 11.069
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.